Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up-Reference-Cited by-同舟云学术

Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up

Published:2021-08-27 Issue: Volume: Page:
ISSN:1932-2259
Container-title:Journal of Cancer Survivorship
language:en
Short-container-title:J Cancer Surviv

Author:

Kurosawa Saiko^ORCID,Yamaguchi Takuhiro,Mori Ayako,Matsuura Tomoko,Mori Takehiko,Tanaka Masatsugu,Kondo Tadakazu,Umemoto Yukari,Goto Hideki,Yoshioka Satoshi,Machida Shinichiro,Sato Takahiko,Katayama Yuta,Kato Seiko,Shono Katsuhiro,Mizuno Ishikazu,Fujiwara Shin-ichiro,Kohno Akio,Takahashi Miyako,Fukuda Takahiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology (nursing),Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11764-021-01092-w.pdf

Reference32 articles.

1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–101.

2. Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, et al. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(7):805–13.

3. Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, et al. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan transplant outcome registry. Bone Marrow Transplant. 2012;10.

4. Tanaka Y, Kurosawa S, Tajima K, Tanaka T, Ito R, Inoue Y, et al. Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016;51(4):553–9.

5. Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, et al. Prevalence of hematopoietic cell transplant survivors in the United States. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013;19(10):1498–501.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective;Transplantation and Cellular Therapy;2024-06

2. American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation Patients;Transplantation and Cellular Therapy;2022-12

3. Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation;Current Hematologic Malignancy Reports;2022-10-04

4. Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation;Journal of Cancer Survivorship;2022-09-01

5. A survey of the support with education and jobs provided by hospitals for hematopoietic cell transplant survivors;Japanese Journal of Transplantation and Cellular Therapy;2022